Mr. Christopher L White, DO Otolaryngology - Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 231 Dawkins Dr, Lewisburg, WV 24901 Phone: 304-645-0870 Fax: 304-645-0970 |
Dr. Robert E Pollard, MD Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Accepting Medicare Assignments Practice Location: 231 Dawkins Dr, Lewisburg, WV 24901 Phone: 304-645-0870 Fax: 304-645-0970 |
News Archive
Congressional Republicans continue to appear divided over what their strategy should be if the Supreme Court strikes down all or part of the health law. More immediately, though, Sen. Orrin Hatch, R-Utah, is targeting the measure's device tax as part of the Senate's consideration of a bill that would reauthorize the Food and Drug Administration user fees.
When applied to HIV care, the community-based model of directly observed therapy has no effect on virologic outcomes, but significantly improves patient survival. This is according to researchers at the Johns Hopkins Bloomberg School of Public Health, in collaboration with colleagues at University of Cape Town, South Africa, who conducted the first randomized controlled trial of patient-nominated treatment-supporters providing partial DOT in resource-limited settings.
HRS, a leading clinical coding and audit services firm in healthcare, is proud to announce that they have been awarded a Multiple Award Schedule (MAS) contract by the General Services Administration (GSA). HRS can now support the coding and audit needs of any governmental agency including all Veteran Administration (VA) hospitals and any other healthcare provider that falls under the federal umbrella. The announcement was made by Wendy Coplan-Gould, RHIA, President of HRS.
DUSA Pharmaceuticals, Inc.®, a specialty pharmaceutical company focused on dermatology, will unveil an ergonomically enhanced BLU-U® Blue Light Photodynamic Therapy Illuminator at this year's American Academy of Dermatology meeting in Miami, Florida, March 5-9. BLU-U, in conjunction with the Levulan® Kerastick® topical treatment, is an integral part of the Levulan® Photodynamic Therapy (PDT) technology platform.
A study by a Columbia University Medical Center researcher shows that 99 percent of participants experienced either a return to menstruation or became pregnant within 90 days after stopping an investigational, low-dose oral contraceptive taken every day without placebo.
› Verified 9 days ago